Ayer Capital Management as of March 31, 2011
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 31 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intermune | 12.3 | $19M | 400k | 47.19 | |
| Celgene Corporation | 8.0 | $12M | 214k | 57.57 | |
| ArthroCare Corporation | 7.3 | $11M | 335k | 33.34 | |
| McKesson Corporation (MCK) | 7.2 | $11M | 139k | 79.05 | |
| Uroplasty | 4.6 | $7.0M | 1.1M | 6.61 | |
| Endocyte | 4.3 | $6.5M | 764k | 8.57 | |
| WellPoint | 4.2 | $6.4M | 91k | 69.79 | |
| Dendreon Corporation | 4.1 | $6.3M | 169k | 37.43 | |
| InterMune | 3.9 | $6.0M | 127k | 47.19 | |
| Hospira | 3.8 | $5.8M | 105k | 55.20 | |
| BioSpecifics Technologies | 3.6 | $5.5M | 216k | 25.50 | |
| Amarin Corp Plc option | 3.5 | $5.4M | 736k | 7.32 | |
| Nps Pharmaceuticals Inc Cmn Stock cmn | 3.1 | $4.8M | 500k | 9.58 | |
| CIGNA Corporation | 2.9 | $4.5M | 101k | 44.28 | |
| Ardea Biosciences | 2.8 | $4.3M | 151k | 28.69 | |
| Mitsui & Co (MITSY) | 2.6 | $4.1M | 971k | 4.19 | |
| ShangPharma | 2.5 | $3.9M | 320k | 12.11 | |
| Express Scripts | 2.3 | $3.6M | 64k | 55.62 | |
| Chelsea Therapeutics International | 2.3 | $3.6M | 921k | 3.88 | |
| Oncothyreon | 1.9 | $2.9M | 757k | 3.87 | |
| Corcept Therapeutics Incorporated (CORT) | 1.8 | $2.8M | 657k | 4.25 | |
| Medco Health Solutions | 1.8 | $2.7M | 48k | 56.16 | |
| Threshold Pharmaceuticals | 1.7 | $2.6M | 1.7M | 1.54 | |
| USD.001 Ibio | 1.3 | $2.0M | 663k | 3.07 | |
| NPS Pharmaceuticals | 1.2 | $1.9M | 200k | 9.58 | |
| Intellipharmaceuticsintl Inc C | 1.2 | $1.9M | 620k | 3.01 | |
| Xenoport | 1.2 | $1.8M | 300k | 5.93 | |
| WuXi PharmaTech | 1.1 | $1.8M | 114k | 15.46 | |
| XenoPort | 0.8 | $1.2M | 204k | 5.93 | |
| Tengion (TNGN) | 0.5 | $721k | 353k | 2.04 | |
| Raptor Pharmaceutical | 0.2 | $307k | 89k | 3.45 |
